School of Medicine
Showing 141-150 of 941 Results
-
Mario Malički
Social Science Research Scholar, Epidemiology and Population Health
Current Role at StanfordAssociate Director of Stanford Program of Research Rigor and Reproducibility (SPORR)
-
Noeen Malik, PhD
Industry Partnership Lead, Operations CRF-1701 Page Mill Rd, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordIndustry Partnership Lead
CRF, MIPS, Stanford School of Medicine, Stanford | May 2024 — present
Lead Radiochemist (R & D Scientist Engineer 2)
CRF, MIPS, Stanford School of Medicine, Stanford | March 2023 — present
Physical Science Research Scientist
CRF, MIPS, Stanford School of Medicine, Stanford | January 2022 — March 2023
Responsibilities:
• R & D of radiopharmaceuticals for oncology and neuroscience
• Industrial collaborations and partnerships
• Drafting and filing drug applications with regulatory agencies (CMCs, INDs)
• Documentation control for audits and in compliance with FDA, Boards of Pharmacy, USP, NRC, and PET CGMP standards.
• Market strategic report for theragnostic-isotopes for Nextgen Cyclotron project
• CRF website development
https://cyclotron.stanford.edu/ -
Kristine Isabel M. Mallari
Clinical Research Rn, Medicine - Primary Care and Population Health
BioKristine is a dedicated Registered Nurse with a Bachelor's Degree in Nursing and nearly a decade of diverse experience in the healthcare field. Throughout her career, she has provided compassionate care to patients across various settings, including inpatient and outpatient environments, as well as specialty areas such as Nephrology Nursing. Her journey has led her to her current role as a Clinical Research Nurse within the Geriatric Research department at Stanford University in the last three years.
-
Parag Mallick
Associate Professor (Research) of Radiology (Diagnostic Sciences Laboratory)
Current Research and Scholarly InterestsThe Mallick Lab is focused on using integrative, multi-omic approaches to model the processes that govern cellular dynamics and to use those models to discover cancer biomarkers and molecular mechanisms.
